Souhaitez-vous accéder aux communiqués récents ?

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial...

TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

HAMPTON, Ga. and SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) --  As unauthorized drone activity surges near critical infrastructure nationwide, Southern States LLC and SkySafe today announced a...

Long-term data from DEVOTE/ONWARD studies show benefits of high dose nusinersen in people living with spinal muscular atrophy (SMA)New Phase 1b data further illustrate potential of salanersen in SMA,...

Completed Phase 2b trial of GH001 in TRD and presented the full dataset at the 2025 ASCP and ECNP congressesGH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCash,...

Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug...

San Diego, CA, March 04, 2026 (GLOBE NEWSWIRE) -- TAP Real Estate Technologies, Inc. (OTC: RWAX) today announced the completion of its corporate name change from HUMBL, Inc. to TAP Real Estate...

Castellum, Inc. Announces 2025 Unaudited Financial Results

ERLANGER, Ky., March 04, 2026 (GLOBE NEWSWIRE) -- DAV (Disabled American Veterans) has announced its continued partnership with Humana, one of the nation’s leading health and well-being companies....

YMCA of the USA presented its inaugural Impact Award to U.S. Senator Susan Collins, R-ME, on Tuesday in Washington, D.C.